EU, method C preference [Two-Stage / GS Designs]

posted by ElMaestro  – Denmark, 2019-10-11 12:25 (1325 d 09:28 ago) – Posting: # 20683
Views: 4,458

Hi all,

I remember having heard EU regulators mention preference for method C out of consideration for the type I error. But I can't seem to find a presentation from anyone saying so. Do you know, do one of you experts have a link or a presentation by a regulator where this was stated?

Many thanks.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
22,614 posts in 4,740 threads, 1,609 registered users;
17 visitors (0 registered, 17 guests [including 9 identified bots]).
Forum time: 21:53 CEST (Europe/Vienna)

For every fact
there is an infinity of hypotheses.    Robert M. Pirsig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5